TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Christine H Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.